Investment Research & Advisory Group, Inc.
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 1802136
ATLANTA, GA
Position in PLX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,330
+$160 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 101 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Investment Research & Advisory Group, Inc. holds $67,444 across 2 Biotechnology names. PLX ranks #2 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
206 | $65,114 | |
| 2 | PLX |
Protalix BioTherapeutics, Inc.
This page
|
1,000 | $2,330 |
All Filings in PLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,330 | 1,000 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,170 | 1,000 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,800 | 1,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,220 | 1,000 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,480 | 1,000 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,536 | 600 | Shares | Sole | 2025-04-21 | |
| No filing history on record for this holder in this stock. | ||||||